Announced Fri, 26 Jun · 19:10 IST
Aarti Drugs trading window closed ahead of Q1 FY27 results
Compliance View source PDF
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹373.50
prior close
₹372.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.1-0.3+1.1+2.4+1.4+3.1+3.4+1.6+4.4+12.3———
Up moveDown movePending
AI summary
Aarti Drugs has informed exchanges that its trading window will remain closed from July 1, 2026 until 48 hours after the declaration of financial results for the quarter ended June 30, 2026 (Q1 FY27). This is a routine compliance measure under SEBI Insider Trading Regulations to prevent insider trading ahead of the results announcement.
Likely market impact
Routine compliance filing. No material impact on the stock. Signals that the Q1 FY27 results announcement is expected in the coming weeks.